JUL 29, 2020 3:00 PM EDT

Advances and trends enabling the growth of immune-based cancer research and therapeutics

C.E. Credits: Florida CE P.A.C.E. CE
Speaker

Abstract

With the recent successes of immunotherapies, a fresh breeze of optimism in the fight against cancer has reinvigorated the industry. Perhaps the greatest legacy will be the realization of the need to understand the interplay within the tumor microenvironment between tumor malignancy and protective immunity. Targeting the liabilities of tumors by ‘tuning’ cellular networks back into homeostatic harmony may just be the key to effective, durable therapies.

Targeting and eliminating pathogenic cells is not good enough on its own to consistently achieve long-term survival. For example, immune cells that can eliminate tumors must persist in hostile, immunosuppressive microenvironments throughout tumor elimination and be capable of renewing protective surveillance. With the emergence of quantitative, live-cell analysis platforms researchers can make the necessary sensitive, time-resolved measurements to monitor the temporal components of an ever evolving cellular network.

This talk will showcase new concepts and strategies to target cancer through an understanding of the immune response. We will discuss purpose-built applications that enable real-time measures of immune cell function, fate and fitness. This tool bench provides the capability to measure, engineer and control immune cell function, thus enabling translational researchers and developers to achieve the necessary level of therapeutic potency and safety

 

Learning Objectives:

1. Define new concepts and understanding of the interplay between tumors and immunity

2. Identify new solutions to model and study tumor immunity over time

3. Key strategies being tested to target tumor liabilities through immune-based drug design


Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 16, 2021 8:00 AM PDT
C.E. CREDITS
SEP 16, 2021 8:00 AM PDT
Date: September 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. T...
JUN 24, 2021 8:00 AM PDT
C.E. CREDITS
JUN 24, 2021 8:00 AM PDT
Date: June 24, 2021 Time: 8:00am (PDT), 11:00am (EDT) Cardiovascular disease is a leading health problem, affecting almost 30% of individuals in the developed world, and comprises a wide ran...
MAY 18, 2021 8:00 AM PDT
C.E. CREDITS
MAY 18, 2021 8:00 AM PDT
Date: May 18, 2021 Time: 8:00am (PST) The global pandemic has caused an increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provide qu...
C.E. CREDITS
The Human Microbiome Project was conceived almost 15 years ago, as an extension of the Human Genome Project, to explore the diversity of human-associated microorganisms at multiple body site...
Loading Comments...
Show Resources